Home > News  > January, 2012

Plea Deal for Surgeon Accused of Sedating and Sexually Assaulting Wife

Surgeon allegedly sedated her with propofol and raped her in his home.

Published:January 4, 2012

Categories:

Dr. Norberg

North Dakota-based orthopedic surgeon Jon Norberg, MD, has pleaded guilty to felony reckless endangerment and a misdemeanor count of sexual assault. The plea agreement comes 6 months after Dr. Norberg allegedly sedated his soon-to-be ex-wife with propofol and raped her in his home. An investigative panel has also recommended that the state's Board of Medical Examiners suspend Dr. Norberg's license indefinitely.

As we reported in August, Dr. Norberg was charged with felony reckless endangerment and gross sexual imposition, a Class AA felony that could have landed the 41-year-old surgeon in prison for life. Dr. Norberg's plea agreement reduced the Class AA felony to a Class B misdemeanor, which upon conviction carries no more than a 30-day jail term. A pre-sentence investigation, expected to take 2 to 3 months, will now be conducted.

Mark McGraw


Also in the News...

Adenotonsillectomy Improves Sleep Apnea in Children

Aetna Sues NJ ASC Over Out-of-Network Practices

Eye Surgeon Not Liable for Prepping Mishap

Did Rushing Cause This Fatal Surgical Error?

Does Your Insurer Have to Pay to Defend You?

Stark Violations Might Cost Tuomey Healthcare System $357M

Tech Walks Out on Surgical Case, Sues Hospital for Firing Him


 
Have an account? Please sign in:
Email Address:
Password:

DID YOU SEE THIS?
Imaging

THIS HIGH-TECH C-ARM SAVES TIME AND MONEY

/_media/adv/web/images/2013/20130101_USWorldMeds_AR-300x250.jpg

Other Articles That May Interest You

Elderly Woman Severely Injured in Fall Off OR Table

Unattended 81-year-old suffered broken bones and head trauma after falling from still-elevated OR table.

Orthopedic Group Absolved for Retained Pain Pump Fragment

Lack of expert testimony dooms patient's malpractice claim.

Ameridose Products Recalled In Wake of Fungal Meningitis Outbreak

As deaths and cases increase, FDA finds "concerns about sterility assurance."